What Hospfar does

Hospfar Indústria e Comércio de Produtos Hospitalares S.A. is a privately-held Brazilian pharmaceutical and medical-hospital product distributor founded on February 1, 1991 in Goiânia, Goiás, and headquartered at Rua 3, 975, Setor Moraes. The company distributes medications (reference, generic, similar, and oncology), hospital materials (including endoprostheses and diabetes diagnostics), laboratory materials, personal hygiene products, and sanitizing agents to public and private hospitals, oncology clinics, social health organizations, and other healthcare establishments across all regions of Brazil. Its product line is supplemented by the "Venda Triangular" service, a triangular sales mechanism for continuous oncology treatments that delivers medication directly to patients' residences with split invoicing between health insurers and patients.

The company operates a nationwide distribution platform anchored by a 13,700 m² infrastructure footprint with 5,200 pallet positions and more than 5,000 active SKUs sourced from major Brazilian and international laboratories. The technology stack is conventional enterprise software rather than AI-native: TOTVS/Protheus ERP, a Warehouse Management System, radiofrequency picking and barcode confirmation, Field Chart temperature and humidity monitoring, and electronic document management. Distribution is supported by an owned fleet for local deliveries plus air-cargo carrier partnerships, enabling 48-hour delivery to all Brazilian capitals and 2-hour response times to hospital demand. Cold chain capabilities include climatized rooms at approximately 20°C and cold chambers at approximately 4°C for thermolabile medications. The company holds ISO 9001 certification (Bureau Veritas, valid 2024-2026), complies with ANVISA's Good Distribution and Storage Practices (RDC 665/2022), and is externally audited by BDO International Limited.

Hospfar's go-to-market is a direct, sales-led B2B model with a dedicated 0800 call center and website-based client acquisition forms, using quote-based, multi-year contracts with healthcare facilities. There is no public revenue disclosure, no external funding or private-equity ownership, and the company appears family-controlled, with Vitor Paiva Perillo as Diretor Superintendente and Marcelo Reis Perillo as Diretor Administrativo. Recent strategic emphasis has been on corporate governance formalization — Deloitte-led compliance program (2021-2022), LGPD compliance, and an independent 24/7 whistleblower channel — rather than aggressive geographic or product expansion, consistent with a mature regional distributor in a stable regulatory environment.

Name

Hospfar

Legal name

Hospfar Indústria e Comércio de Produtos Hospitalares S.A.

Website

https://hospfar.com.br

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

251–500 employees

Short description

Hospfar is a privately-held Brazilian pharmaceutical and medical-hospital product distributor, founded in 1991 in Goiânia, serving public and private hospitals, oncology clinics, and social health organizations nationwide through a multi-branch distribution platform with cold-chain logistics and ISO 9001 certification.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Controlled Substances & Compliance-Focused Pharmaceutical Distributors (HLAIAJAN)

Keywords

• Pharmaceutical distribution
• Hospital product supply
• Cold chain logistics
• Medical material distribution
• Healthcare supply chain

Headquarters

HQ city

Goiânia

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution: Distribution of medications, hospital materials, laboratory materials, and equipment to healthcare facilities. Revenue generated through sale of pharmaceutical and medical products to hospitals, clinics, and healthcare organizations.
2. Triangular Sales (Venda Triangular): Innovative triangular sales approach for continuous treatments, especially oncology medications. Process involves issuing two invoices: one for health insurance operator and one for the patient, enabling direct delivery to patient's residence.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Hospfar distributes medications (reference, generic, similar, and oncology drugs), hospital materials (endoprostheses, diabetes diagnostics), laboratory materials, personal hygiene products, and sanitizing agents to public and private hospitals, oncology clinics, social health organizations, and healthcare establishments across Brazil. The company provides cold chain storage and transport, full cargo traceability, and a triangular sales service that delivers continuous-treatment medications directly to oncology patients' residences.

Product overview

Hospfar is a pharmaceutical and medical-hospital product distribution company operating since 1991. The company offers a portfolio of medications (reference, generic, similar, and oncology drugs), hospital materials (endoprostheses and diabetes diagnostic lines), laboratory materials, personal hygiene products, and sanitizing agents. Logistics services include cold chain storage and transport, cargo traceability, and the innovative triangular sales service for direct patient delivery. The company also provides compliance services including an independent integrity channel and ethics programs developed with Deloitte.

Differentiator

Problem solved

Functional benefit

Products and services

• Medicamentos Hospitalares (Hospital Medications) Reference, generic, similar, and oncology medications for hospital and clinical use, including continuous and specialized treatment medications, sold to public and private hospitals and oncology clinics.
• Materiais Hospitalares (Hospital Materials) Hospital materials including endoprostheses and diabetes diagnostic product lines used in medical procedures and patient care, distributed to healthcare facilities.
• Materiais para Laboratórios (Laboratory Materials) Laboratory materials supporting diagnostic and testing operations in healthcare facilities and clinical laboratories.
• Produtos de Higiene Pessoal (Personal Hygiene Products) Personal hygiene products including geriatric diapers and cosmetics for body care in aesthetic and health contexts, distributed to healthcare facilities.
• Saneantes (Sanitizing Products) Sanitizing products that facilitate cleaning and conservation of healthcare environments, following ANVISA standards to reduce hospital infection rates.
• Venda Triangular (Triangular Sales) Innovative triangular sales service for continuous oncology treatments where medication is delivered directly to the patient's residence, with two invoices issued — one to the health insurance operator and one to the patient — enabling direct home delivery with agility and safety.
• Cadeia Fria (Cold Chain Logistics) Temperature-controlled storage and transportation service with refrigerated chambers at approximately 4°C and air-conditioned rooms at 20°C for thermolabile medications, including automatic temperature and humidity monitoring via Field Chart software.
• Rastreabilidade de Cargas (Cargo Tracking and Traceability) Cargo tracking and traceability service ensuring full visibility from origin to final destination with online tracking and monitoring of all deliveries, including risk management for nationwide deliveries.

Quantifiable outcome

• Delivery to all Brazilian capitals within 48 hours
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and flagship.

• Bureau VeritascoreOthers · 1 January 2024Bureau Veritas is the certification body for Hospfar's ISO 9001 quality management system certification, valid through 2024-2026.
• DeloittecoreStrategic or Co-development Partner · 1 January 2021Hospfar partnered with Deloitte for compliance program implementation. Deloitte conducted training for leaders and collaborators on the new compliance program, code of conduct, and ethics. Deloitte is recognized for its certified and expert professionals in compliance matters.
• PfizerflagshipStrategic or Co-development Partner · 1 January 2010Pfizer partnership recognized as 'Success Partnership' (Parceria de Sucesso) in 2010. One of Hospfar's key pharmaceutical manufacturer partnerships.
• SanofiflagshipStrategic or Co-development Partner · 1 January 2010Sanofi partnership recognized as 'Reference Partner' (Parceiro de Referência) in 2010. Key pharmaceutical manufacturer partner for Hospfar.
• BDO International LimitedcoreOthersHospfar is audited by BDO International Limited, an internationally renowned auditing firm. This partnership ensures compliance with international auditing standards.
• ANVISAcoreOthersRegulatory partnership with Brazil's National Health Surveillance Agency. Hospfar adopts Good Distribution and/or Storage Practices normalized by ANVISA, including RDC Resolution No. 665 of 2022.

Scale indicators5 records

Recent moves11 records

Expansion highlights5 records

Direct peers

• Unidrogas: Cooperative pharmaceutical distributor serving affiliated drugstores across Brazil. Comparable to Hospfar in pharma distribution operations, regulatory compliance focus, and multi-region logistics.
• Santa Cruz Distribuidora: Brazilian pharmaceutical and hospital supplies distributor with strong regional presence. Comparable to Hospfar in serving hospitals and clinics with branded and generic medications across multiple therapeutic categories.
• Topaz Distribuidora: Brazilian pharmaceutical distributor with nationwide operations serving drugstores and hospital channels. Comparable to Hospfar in core B2B pharma distribution activities, customer mix, and supply chain operations.
• Profarma Distribuidora (Hypera Pharma): One of Brazil's largest pharmaceutical distributors serving retail and institutional customers with a national footprint. Directly comparable to Hospfar in pharma distribution business model, though at substantially greater scale and now part of Hypera Pharma.

Broad incumbents

• EMS Pharma: Largest Brazilian pharmaceutical manufacturer by volume with significant distribution infrastructure. Comparable to Hospfar in scale of pharmaceutical supply chain operations, though vertically integrated into manufacturing.
• Pague Menos: Brazilian retail pharmacy chain with centralized distribution operations. Comparable to Hospfar in pharmaceutical distribution infrastructure and scale, though primarily retail-focused.
• Dimed (Panvel): Brazilian retail pharmacy chain operator with a distribution arm supplying its own stores. Overlaps with Hospfar in pharmaceutical distribution infrastructure, though primarily retail-facing rather than hospital-focused.
• Eurofarma: Major Brazilian pharmaceutical manufacturer with proprietary distribution operations. Comparable to Hospfar as a participant in Brazilian pharmaceutical supply chain, though operating primarily as a manufacturer rather than third-party distributor.
• RD Saúde (Raia Drogasil): Largest drug retail chain in Brazil with significant distribution operations. Comparable to Hospfar in pharmaceutical supply chain capabilities, though focused on retail rather than institutional/hospital customers.

Emerging players

• McKesson: Global pharmaceutical distributor with growing presence in Brazil. Comparable to Hospfar in pharmaceutical distribution business model, though operating at vastly greater scale globally with a developing Brazilian footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/hospfaroficial
• Instagraminstagram.com/hospfaroficial

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospfar